Science & Technology

EGT’s strategy for the development of new therapeutics for life threatening diseases is based upon the concept of “genetic medicine” in which disease is viewed in the context of the qualities of genes and their effects on the health of human beings. As a result of the massive world-wide effort to understand the complexity and operation of the human genome, medical researchers are now able to better understand the molecular basis of many diseases and devise strategies to correct the errant gene expression which is the predominant causative factor of the disease process.

EGT is focusing its efforts on product development using two technologies, gene therapy and the chemical modulation of the genetic chromatin structure. Both approaches correct gene expression and are expected to result into important therapeutic products.